Harrow Health, Inc.HROWNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +83.83% | +38.29% | +30.25% | +45.44% | +33.31% |
| Gross Profit Growth | +110.34% | +34.42% | +30.53% | +44.81% | +34.02% |
| EBITDA Growth | +0.00% | +0.00% | +264.89% | +171.78% | -2.12% |
| Operating Income Growth | +0.00% | +0.00% | +645.69% | +1016.35% | +20.87% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -2.23% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -5.26% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -5.26% |
| Weighted Average Shares Growth | +1.28% | +1.00% | +3.29% | +4.04% | +2.66% |
| Weighted Average Shares Diluted Growth | +1.28% | +1.00% | +9.08% | +8.89% | +2.66% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -304.45% | +0.00% | +0.00% | +462.11% | +0.00% |
| Free Cash Flow Growth | -751.58% | +0.00% | +0.00% | +597.83% | +0.00% |
| Receivables Growth | +219.55% | +164.80% | +50.95% | +44.23% | -4.89% |
| Inventory Growth | -1.52% | -0.87% | +22.57% | +26.37% | -100.00% |
| Asset Growth | +24.77% | +23.22% | +12.52% | +3.28% | +2.70% |
| Book Value per Share Growth | -2.26% | -7.71% | -17.87% | -22.06% | -26.65% |
| Debt Growth | +20.12% | +20.01% | +20.23% | +28.46% | +10.12% |
| R&D Expense Growth | +42.54% | +40.81% | -6.06% | +46.19% | +146.54% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |